Sylvester, Dana-Farber researchers receive $7M from PCORI to study diet, exercise effects on mental and physical functioning in older cancer survivors

NYU Langone, Dana-Farber deploy oncology decision support platform

NYU Langone Health and Dana-Farber Cancer Institute have formed a strategic collaboration to co-develop Solavia Decision Suite, an oncology support platform designed to improve cancer care for patients and clinicians.

August 07, 2026

Vol.52 No.31

In Brief

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Dana-Farber Cancer Institute’s Department of Pathology, in collaboration with Brigham and Women’s Hospital, has received renewed funding for the Ruth L. Kirschstein NRSA Institutional Research Training Grant from the NCI, providing resources for pathology residents, clinical fellows, and PhD-trained scientists pursuing research careers in cancer pathology.

August 07, 2026

Vol.52 No.31

In Brief

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Marlon L. Wong, associate professor of clinical physical therapy at the University of Miami Miller School of Medicine, was awarded a grant from Gabrielle’s Angel Foundation for Cancer Research. The three-year, $225,000 award will support research focused on improving quality of life for patients living with chemotherapy-induced peripheral neuropathy and other long-term effects of cancer treatment.

July 24, 2026

Vol.52 No.29

In Brief

Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital

Dana-Farber Cancer Institute announced the name of its 300-bed, freestanding cancer hospital, which is now under construction and will span 450,000 square feet across 10 inpatient floors: the Lavine Bekenstein Cancer Hospital. The building is expected to open in 2031.

June 26, 2026

Vol.52 No.25

Clinical Roundup

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to a study led by researchers at Sylvester Comprehensive Cancer Center.

June 26, 2026

Vol.52 No.25

In Brief

Mina Sedrak and Vijaya Raj Bhatt to co-lead Alliance’s committee on cancer care for older adults

Mina Sedrak, director of the UCLA Center for Cancer and Aging and director of Cancer Control and Survivorship Research at the UCLA Health Jonsson Comprehensive Cancer Center, and Vijaya Raj Bhatt professor and medical director of the Leukemia Program at the University of Nebraska Medical Center, were selected to serve as co-chairs of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology.

June 05, 2026

Vol.52 No.22

Sylvester, Dana-Farber researchers receive $7M from PCORI to study diet, exercise effects on mental and physical functioning in older cancer survivors

YOU MAY BE INTERESTED IN

NYU Langone, Dana-Farber deploy oncology decision support platform

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital

Sylvester researchers discover method of disrupting inflammatory network that helps pancreatic cancer resist treatment

Mina Sedrak and Vijaya Raj Bhatt to co-lead Alliance’s committee on cancer care for older adults

Renew today!

Subscriber content

Never miss an issue!

Login